Program: CASL Single Topic Conference on Steatotic Liver Disease

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by Canadian Association for the Study of the Liver. You may claim a maximum of 7.5 hours (credits are automatically calculated).

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to
AMA credit can be found at www.ama-assn.org/go/internationalcme.

Friday, September 18, 2026
5:00 PM - 6:00 PM																Joint Reception with L'Association des gastro-entérologues du Québec's (AGEQ), Journée André-Viallet (JAV) 2026
6:00 PM - 7:00 PM																Opening Session: Keynote Moderated by Sahar Saeed and Jennifer Flemming Featuring Opening Remarks with Sahar Saeed and Jennifer Flemming Keynote Presentation on From ‘Best Buys’ to ‘Right Now’: Global Policy Levers for Liver Health with Jeffrey Lazarus
Saturday, September 19, 2026
9:00 AM - 10:20 AM																Session 1: Epidemiology (Causes) & Prevention The Pro-SLD Environment: Rethinking Causes and Prevention Moderated by Jessica Burnside Featuring From NAFLD to SLD: Precision, Stigma, and Clinical Consequences (Tie to Diabetes/CASL guidelines) with Giada Sebastiani Alcohol and SLD: Beyond Consumption to Risk Context with Jennifer Flemming Obesity, Metabolism, and the SLD Continuum with Michael Tsoukas Food and physical activity and Liver Health: The Hidden Drivers with Chantal Bemeur Q&A /Panel: Prevention at Scale: What Actually Works? with all speakers
10:20 AM - 10:40 AM																Morning Break
10:40 AM - 11:40 AM																Session 2: Early Detection/Pathways Early Detection That Works: From Diagnostics to Systems Moderated by Mark Swain and Duy Dinh Featuring Finding SLD Earlier: From Tools to Real-World Pathways with Nicola Pugliese Why Screening Fails: Implementation barriers in Canadian Care Pathways with Sahar Saeed Task-Shifting in Action: Nurse-Led Models for SLD Care with Magdalena Kuczynski Q&A /Panel: Scaling Detection: What Will It Take? with all speakers
11:40 AM - 11:45 AM																Stretch Break
11:45 AM - 12:30 PM																Session 3: Panel Discussion Taking Care of People, Not Organs: Advancing Equitable and Person-Centered Care in the SLD Era Moderated by Trevor Murphy Featuring Perspectives from the Fatty Liver Alliance (FLA) with Michael Betel Perspectives from Le Réseau de recherche sur la santé cardiométabolique, le diabète et l’obésité (CMDO) with Fannie Lajeunesse-Trempe
12:30 PM - 1:30 PM																Lunch Break
1:30 PM - 3:05 PM																Session 4: Therapeutic Innovation The MASH Moment: Therapeutics and the Future of SLD Care Moderated by Marc Bilodeau and Amine Benmassaoud Featuring Metabolic Management: The Endocrinology Perspective on SLD with Vanessa Tardio Pathways for management Hepatology with Alnoor Ramji Frontline SLD Care: The Role of Primary Care with James Kim Cardiovascular risk assessment in patients with MASLD with George Thanassoulis What’s Coming Next? Inside the MASH Pipeline with Mark Swain Q&A /Panel: Who Should Be Treated—and by Who? with all speakers
3:05 PM - 3:20 PM																Afternoon Break
3:20 PM - 4:25 PM																Session 5: No One-Size-Fits-All SLD Across Sex, Gender, and Life Course Moderated by Giada Sebastiani and Jennifer Flemming Featuring Women and SLD: Hormones, Risk, and Missed Opportunities with Monika Sarkar Early Life, Lifelong Risk: Pediatric SLD with Mohit Kehar Gender-Diverse Health and SLD: Gaps and Opportunities with Tzu-Hao (Howard) Lee Q&A /Panel: Who are we missing? with all speakers
4:25 PM - 4:30 PM																Closing